News

The venture capital firm invests in pre-Series A technology companies in the agriculture and food supply chain.

The firm is seeking $400m for NewView Capital Fund III and $300m for NewView Capital Special Opportunities Fund III.

The Swedish firm spent two years fundraising in an 'undeniably challenging' market, says partner Johanna Levander.

Forbion, a life sciences venture capital firm, has held a first close on €75m for Forbion BioEconomy Fund I, which is targeting €150m.

Index Ventures has raised $800 million for its 12th venture fund and $1.5 billion for its seventh growth fund.

Private capital has started flowing towards climate finance, but is unevenly spread across strategies and sectors, leaving a growth equity 'missing middle,' says a new CREO report.

The convoluted structure of the healthcare industry and unique challenges of technology adoption give VCs with experience as clinicians and operators an advantage, says Zoi Capital co-founder Dr. Ronald Razmi.

About 20% of Industry Ventures Partnership Holding VII will be dedicated to purchasing LP stakes in venture funds, says senior managing director Roland Reynolds.

New and existing VC secondaries players have raised billions in fresh capital as liquidity needs show no signs of slowing.

The market for humanoid robots may approach $40bn in about 10 years as these nimble machines take on jobs that are repetitive or dangerous and where turnover is high.